SK1032001A3 - Alpha-amino acid phenyl ester derivatives - Google Patents

Alpha-amino acid phenyl ester derivatives Download PDF

Info

Publication number: SK1032001A3
Authority: SK; Slovakia
Prior art keywords: acid; amino; amino acid; alkyl; dimethoxyphenyl
Prior art date: 1998-07-22

Application number

SK103-2001A

Other languages

English (en)

Slovak (sk)

Inventor

Niall Morton Hamilton

Original Assignee

Akzo Nobel Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-22

Filing date

1999-07-16

Publication date

2001-08-06

1999-07-16 Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv

2001-08-06 Publication of SK1032001A3 publication Critical patent/SK1032001A3/sk

Links

-1 Alpha-amino acid phenyl ester Chemical class 0.000 title claims abstract description 99
235000008206 alpha-amino acids Nutrition 0.000 title claims abstract description 26
125000000217 alkyl group Chemical group 0.000 claims abstract description 25
150000003839 salts Chemical class 0.000 claims abstract description 18
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 14
125000003545 alkoxy group Chemical group 0.000 claims abstract description 13
230000000147 hypnotic effect Effects 0.000 claims abstract description 11
125000003342 alkenyl group Chemical group 0.000 claims abstract description 10
239000001257 hydrogen Substances 0.000 claims abstract description 6
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 6
125000000304 alkynyl group Chemical group 0.000 claims abstract description 5
125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 5
125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract description 4
125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 3
125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
150000001875 compounds Chemical class 0.000 claims description 45
KLIDCXVFHGNTTM-UHFFFAOYSA-N 2,6-dimethoxyphenol Chemical group COC1=CC=CC(OC)=C1O KLIDCXVFHGNTTM-UHFFFAOYSA-N 0.000 claims description 14
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 8
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
229960003692 gamma aminobutyric acid Drugs 0.000 claims description 7
150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 6
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
229910052799 carbon Inorganic materials 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 4
239000003814 drug Substances 0.000 claims description 3
239000000546 pharmaceutical excipient Substances 0.000 claims description 3
208000019901 Anxiety disease Diseases 0.000 claims description 2
206010010904 Convulsion Diseases 0.000 claims description 2
201000009916 Postpartum depression Diseases 0.000 claims description 2
206010036618 Premenstrual syndrome Diseases 0.000 claims description 2
230000036506 anxiety Effects 0.000 claims description 2
201000010099 disease Diseases 0.000 claims description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 2
201000000484 premenstrual tension Diseases 0.000 claims description 2
239000000932 sedative agent Substances 0.000 claims description 2
230000000202 analgesic effect Effects 0.000 claims 1
230000001624 sedative effect Effects 0.000 claims 1
238000002560 therapeutic procedure Methods 0.000 claims 1
239000003326 hypnotic agent Substances 0.000 abstract description 5
206010002091 Anaesthesia Diseases 0.000 abstract description 3
230000037005 anaesthesia Effects 0.000 abstract description 3
230000006698 induction Effects 0.000 abstract description 2
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
238000001949 anaesthesia Methods 0.000 abstract 1
238000012423 maintenance Methods 0.000 abstract 1
238000005481 NMR spectroscopy Methods 0.000 description 61
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 61
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 45
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
150000002500 ions Chemical class 0.000 description 25
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
239000000243 solution Substances 0.000 description 24
JUJWROOIHBZHMG-RALIUCGRSA-N pyridine-d5 Chemical compound [2H]C1=NC([2H])=C([2H])C([2H])=C1[2H] JUJWROOIHBZHMG-RALIUCGRSA-N 0.000 description 19
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
239000000203 mixture Substances 0.000 description 16
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 12
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 10
150000002148 esters Chemical class 0.000 description 10
239000007787 solid Substances 0.000 description 10
IHMGFZLHMQPGRB-UHFFFAOYSA-N (2,6-dimethoxyphenyl) butanoate Chemical compound CCCC(=O)OC1=C(OC)C=CC=C1OC IHMGFZLHMQPGRB-UHFFFAOYSA-N 0.000 description 9
239000002904 solvent Substances 0.000 description 9
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
125000004432 carbon atom Chemical group C* 0.000 description 8
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 7
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 7
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
QRPQVVRHSVAUCY-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) butanoate Chemical compound CCCC(=O)OC1=C(OC)C=C(C=C1OC)C QRPQVVRHSVAUCY-UHFFFAOYSA-N 0.000 description 6
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
239000002253 acid Substances 0.000 description 6
238000004587 chromatography analysis Methods 0.000 description 6
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
239000011541 reaction mixture Substances 0.000 description 6
UOAAWEZUMVNYAT-UHFFFAOYSA-N (2,6-dimethoxyphenyl) propanoate Chemical compound CCC(=O)OC1=C(OC)C=CC=C1OC UOAAWEZUMVNYAT-UHFFFAOYSA-N 0.000 description 5
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
239000012043 crude product Substances 0.000 description 5
238000001990 intravenous administration Methods 0.000 description 5
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
238000000034 method Methods 0.000 description 5
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
239000011734 sodium Substances 0.000 description 5
PASDZKDXDGIFPU-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) propanoate Chemical compound CCC(=O)OC1=C(OC)C=C(C)C=C1OC PASDZKDXDGIFPU-UHFFFAOYSA-N 0.000 description 4
ZFBNNSOJNZBLLS-UHFFFAOYSA-N 2,6-Dimethoxy-4-methylphenol Chemical compound COC1=CC(C)=CC(OC)=C1O ZFBNNSOJNZBLLS-UHFFFAOYSA-N 0.000 description 4
PBIUDEUWYGBHDW-UHFFFAOYSA-N 2-chloro-1-pyridin-3-ylethanone;hydrochloride Chemical compound Cl.ClCC(=O)C1=CC=CN=C1 PBIUDEUWYGBHDW-UHFFFAOYSA-N 0.000 description 4
BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 4
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
229910052794 bromium Inorganic materials 0.000 description 4
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
239000003480 eluent Substances 0.000 description 4
239000000284 extract Substances 0.000 description 4
239000000543 intermediate Substances 0.000 description 4
239000010410 layer Substances 0.000 description 4
239000007788 liquid Substances 0.000 description 4
229910052943 magnesium sulfate Inorganic materials 0.000 description 4
235000019341 magnesium sulphate Nutrition 0.000 description 4
239000012074 organic phase Substances 0.000 description 4
239000000741 silica gel Substances 0.000 description 4
229910002027 silica gel Inorganic materials 0.000 description 4
229910052938 sodium sulfate Inorganic materials 0.000 description 4
235000011152 sodium sulphate Nutrition 0.000 description 4
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
238000005160 1H NMR spectroscopy Methods 0.000 description 3
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
VTBHBNXGFPTBJL-UHFFFAOYSA-N 4-tert-butyl-1-sulfanylidene-2,6,7-trioxa-1$l^{5}-phosphabicyclo[2.2.2]octane Chemical compound C1OP2(=S)OCC1(C(C)(C)C)CO2 VTBHBNXGFPTBJL-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000009833 condensation Methods 0.000 description 3
230000005494 condensation Effects 0.000 description 3
239000000706 filtrate Substances 0.000 description 3
239000003193 general anesthetic agent Substances 0.000 description 3
150000002989 phenols Chemical class 0.000 description 3
239000000725 suspension Substances 0.000 description 3
GWNIEAJQMCBQHC-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-bromobutanoate Chemical compound CCC(Br)C(=O)OC1=C(OC)C=C(C)C=C1OC GWNIEAJQMCBQHC-UHFFFAOYSA-N 0.000 description 2
MCTFQDODOWYOIR-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-bromohexanoate Chemical compound CCCCC(Br)C(=O)OC1=C(OC)C=C(C)C=C1OC MCTFQDODOWYOIR-UHFFFAOYSA-N 0.000 description 2
QCQWVVNWUYVAGV-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-morpholin-4-ylpropanoate Chemical compound COC1=CC=CC(OC)=C1OC(=O)C(C)N1CCOCC1 QCQWVVNWUYVAGV-UHFFFAOYSA-N 0.000 description 2
NNFDHJQLIFECSR-UHFFFAOYSA-N 2-bromo-4-methylpentanoic acid Chemical compound CC(C)CC(Br)C(O)=O NNFDHJQLIFECSR-UHFFFAOYSA-N 0.000 description 2
IQGRVWSONWFJJD-UHFFFAOYSA-N 2-bromo-4-methylpentanoyl chloride Chemical compound CC(C)CC(Br)C(Cl)=O IQGRVWSONWFJJD-UHFFFAOYSA-N 0.000 description 2
IBZKBSXREAQDTO-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)ethanamine Chemical compound COCCNCCOC IBZKBSXREAQDTO-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
PXALERQQASXBPS-UHFFFAOYSA-N COC1=C(C(=CC=C1)OC)OC(CCCC)=O Chemical compound COC1=C(C(=CC=C1)OC)OC(CCCC)=O PXALERQQASXBPS-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
102000027484 GABAA receptors Human genes 0.000 description 2
108091008681 GABAA receptors Proteins 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
230000003444 anaesthetic effect Effects 0.000 description 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
230000027455 binding Effects 0.000 description 2
230000037396 body weight Effects 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
239000002775 capsule Substances 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
239000012458 free base Substances 0.000 description 2
239000007789 gas Substances 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000003589 local anesthetic agent Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000007911 parenteral administration Methods 0.000 description 2
235000019260 propionic acid Nutrition 0.000 description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
239000007921 spray Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
IATCKPOMRWDEIO-UHFFFAOYSA-N (2,4,6-trimethoxyphenyl) butanoate Chemical compound COC1=C(C(=CC(=C1)OC)OC)OC(CCC)=O IATCKPOMRWDEIO-UHFFFAOYSA-N 0.000 description 1
VDWTULHAMBAZHU-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-(diethylamino)propanoate Chemical compound CCN(CC)C(C)C(=O)OC1=C(OC)C=C(C)C=C1OC VDWTULHAMBAZHU-UHFFFAOYSA-N 0.000 description 1
FHJSMMINOSVKLF-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-[2-methoxyethyl(methyl)amino]-4-methylpentanoate Chemical compound COCCN(C)C(CC(C)C)C(=O)OC1=C(OC)C=C(C)C=C1OC FHJSMMINOSVKLF-UHFFFAOYSA-N 0.000 description 1
IJFMWPGDKQZIAC-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-[benzyl(methyl)amino]propanoate Chemical compound COC1=CC(C)=CC(OC)=C1OC(=O)C(C)N(C)CC1=CC=CC=C1 IJFMWPGDKQZIAC-UHFFFAOYSA-N 0.000 description 1
AZORXPWSCIGVTE-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-bromo-3-methylbutanoate Chemical compound COC1=CC(C)=CC(OC)=C1OC(=O)C(Br)C(C)C AZORXPWSCIGVTE-UHFFFAOYSA-N 0.000 description 1
ITETUAIEFAYHJR-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-bromo-4-methylpentanoate Chemical compound COC1=CC(C)=CC(OC)=C1OC(=O)C(Br)CC(C)C ITETUAIEFAYHJR-UHFFFAOYSA-N 0.000 description 1
BOIAKKNKVBLOTH-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) 2-bromopropanoate Chemical compound COC1=CC(C)=CC(OC)=C1OC(=O)C(C)Br BOIAKKNKVBLOTH-UHFFFAOYSA-N 0.000 description 1
YXKGAPMZAGMSGB-UHFFFAOYSA-N (2,6-dimethoxy-4-methylphenyl) pentanoate Chemical compound COC1=C(C(=CC(=C1)C)OC)OC(CCCC)=O YXKGAPMZAGMSGB-UHFFFAOYSA-N 0.000 description 1
UBFKWISSGSHAJR-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-[[(3-ethoxy-3-oxopropyl)amino]-(3-methoxy-3-oxopropyl)amino]butanoate Chemical compound CCOC(=O)CCNN(CCC(=O)OC)C(CC)C(=O)OC1=C(OC)C=CC=C1OC UBFKWISSGSHAJR-UHFFFAOYSA-N 0.000 description 1
CDNYTKZXPHHBMR-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-[benzyl(methyl)amino]butanoate Chemical compound COC=1C=CC=C(OC)C=1OC(=O)C(CC)N(C)CC1=CC=CC=C1 CDNYTKZXPHHBMR-UHFFFAOYSA-N 0.000 description 1
DHAVDCJOKDGNDU-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-[methyl(2-phenylethyl)amino]propanoate Chemical compound COC1=CC=CC(OC)=C1OC(=O)C(C)N(C)CCC1=CC=CC=C1 DHAVDCJOKDGNDU-UHFFFAOYSA-N 0.000 description 1
GXPNUTSVHMPUFF-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-bromo-4-methylpentanoate Chemical compound COC1=CC=CC(OC)=C1OC(=O)C(Br)CC(C)C GXPNUTSVHMPUFF-UHFFFAOYSA-N 0.000 description 1
SMDSHHLBPUPGTD-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-bromobutanoate Chemical compound CCC(Br)C(=O)OC1=C(OC)C=CC=C1OC SMDSHHLBPUPGTD-UHFFFAOYSA-N 0.000 description 1
BJQQIMSRZRHGRF-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-bromohexanoate Chemical compound CCCCC(Br)C(=O)OC1=C(OC)C=CC=C1OC BJQQIMSRZRHGRF-UHFFFAOYSA-N 0.000 description 1
IFRQHSUHKKOCKD-UHFFFAOYSA-N (2,6-dimethoxyphenyl) 2-bromopropanoate Chemical compound COC1=CC=CC(OC)=C1OC(=O)C(C)Br IFRQHSUHKKOCKD-UHFFFAOYSA-N 0.000 description 1
OOSZCNKVJAVHJI-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]piperazine Chemical compound C1=CC(F)=CC=C1CN1CCNCC1 OOSZCNKVJAVHJI-UHFFFAOYSA-N 0.000 description 1
HHKDBXNYWNUHPL-UHFFFAOYSA-N 2-bromobutanoyl bromide Chemical compound CCC(Br)C(Br)=O HHKDBXNYWNUHPL-UHFFFAOYSA-N 0.000 description 1
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
GDSKWOQXKCXCHJ-UHFFFAOYSA-N CC(C)CC(C(=O)OC1=C(C=CC=C1OC)OC)N(C)CCOC Chemical compound CC(C)CC(C(=O)OC1=C(C=CC=C1OC)OC)N(C)CCOC GDSKWOQXKCXCHJ-UHFFFAOYSA-N 0.000 description 1
LHRWNDUMJIJDGK-UHFFFAOYSA-N CCCC(OC(C(OCC)=CC=C1)=C1OCC)=O Chemical compound CCCC(OC(C(OCC)=CC=C1)=C1OCC)=O LHRWNDUMJIJDGK-UHFFFAOYSA-N 0.000 description 1
SYTKZXLJRBFTAC-UHFFFAOYSA-N COCCN(C)C(C)C(=O)OC1=C(OC)C=CC=C1OC Chemical compound COCCN(C)C(C)C(=O)OC1=C(OC)C=CC=C1OC SYTKZXLJRBFTAC-UHFFFAOYSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
NBMYFQDSCYDPBC-UHFFFAOYSA-N Cl.CCN(CC)C(C)C(=O)OC1=C(OC)C=C(C)C=C1OC Chemical compound Cl.CCN(CC)C(C)C(=O)OC1=C(OC)C=C(C)C=C1OC NBMYFQDSCYDPBC-UHFFFAOYSA-N 0.000 description 1
JMMRQPPBNUJIHQ-UHFFFAOYSA-N Cl.COC1=CC(C)=CC(OC)=C1OC(=O)C(C)N(C)CC1=CC=CC=C1 Chemical compound Cl.COC1=CC(C)=CC(OC)=C1OC(=O)C(C)N(C)CC1=CC=CC=C1 JMMRQPPBNUJIHQ-UHFFFAOYSA-N 0.000 description 1
ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 1
229930182819 D-leucine Natural products 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
108090000371 Esterases Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
229920002472 Starch Chemical class 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
241000906446 Theraps Species 0.000 description 1
239000000654 additive Substances 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
235000001014 amino acid Nutrition 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
238000012435 analytical chromatography Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
239000007900 aqueous suspension Substances 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
229940125717 barbiturate Drugs 0.000 description 1
239000002585 base Substances 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
235000010290 biphenyl Nutrition 0.000 description 1
239000004305 biphenyl Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
150000001723 carbon free-radicals Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000001913 cellulose Chemical class 0.000 description 1
229920002678 cellulose Chemical class 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
239000007810 chemical reaction solvent Substances 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
JFUGLUDIJIDWLI-UHFFFAOYSA-N diethylamino butanoate Chemical compound CCCC(=O)ON(CC)CC JFUGLUDIJIDWLI-UHFFFAOYSA-N 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
235000019800 disodium phosphate Nutrition 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
238000010931 ester hydrolysis Methods 0.000 description 1
XEKOWRVHYACXOJ-UHFFFAOYSA-N ethyl acetate Substances CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 1
125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
230000003371 gabaergic effect Effects 0.000 description 1
238000002695 general anesthesia Methods 0.000 description 1
229940005494 general anesthetics Drugs 0.000 description 1
239000008187 granular material Substances 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
125000006038 hexenyl group Chemical group 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
229910000041 hydrogen chloride Inorganic materials 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
239000005457 ice water Substances 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
229960005015 local anesthetics Drugs 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
YYTWEEOFRNSTKS-UHFFFAOYSA-N n,n'-dicyclohexylmethanediimine;1-hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1.C1CCCCC1N=C=NC1CCCCC1 YYTWEEOFRNSTKS-UHFFFAOYSA-N 0.000 description 1
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
PUUZLWLFYQFYCF-UHFFFAOYSA-N n-ethylethanamine;hexane;propan-2-ol Chemical compound CC(C)O.CCNCC.CCCCCC PUUZLWLFYQFYCF-UHFFFAOYSA-N 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
229940097496 nasal spray Drugs 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
GODHIFXMNKQHEI-UHFFFAOYSA-N pentanoic acid;hydrochloride Chemical compound Cl.CCCCC(O)=O GODHIFXMNKQHEI-UHFFFAOYSA-N 0.000 description 1
125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
125000005981 pentynyl group Chemical group 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
125000004193 piperazinyl group Chemical group 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000004237 preparative chromatography Methods 0.000 description 1
OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
239000002287 radioligand Substances 0.000 description 1
230000011514 reflex Effects 0.000 description 1
238000010992 reflux Methods 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
238000000926 separation method Methods 0.000 description 1
208000019116 sleep disease Diseases 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
229940074545 sodium dihydrogen phosphate dihydrate Drugs 0.000 description 1
HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
229940001584 sodium metabisulfite Drugs 0.000 description 1
235000010262 sodium metabisulphite Nutrition 0.000 description 1
235000010344 sodium nitrate Nutrition 0.000 description 1
239000004317 sodium nitrate Substances 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
239000008107 starch Chemical class 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
239000010409 thin film Substances 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SK103-2001A 1998-07-22 1999-07-16 Alpha-amino acid phenyl ester derivatives SK1032001A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98305837		1998-07-22
PCT/EP1999/005051 WO2000005196A1 (en)	1998-07-22	1999-07-16	α-AMINO ACID PHENYL ESTER DERIVATIVES

Publications (1)

Publication Number	Publication Date
SK1032001A3 true SK1032001A3 (en)	2001-08-06

Family

ID=8234960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK103-2001A SK1032001A3 (en)	1998-07-22	1999-07-16	Alpha-amino acid phenyl ester derivatives

Country Status (27)

Country	Link
US (1)	US6451854B1 (de)
EP (1)	EP1098871B1 (de)
JP (1)	JP2002521358A (de)
KR (1)	KR100599142B1 (de)
CN (1)	CN1183101C (de)
AR (1)	AR021165A1 (de)
AT (1)	ATE244697T1 (de)
AU (1)	AU758808B2 (de)
BR (1)	BR9912291A (de)
CA (1)	CA2337945A1 (de)
CO (1)	CO5080742A1 (de)
DE (1)	DE69909486T2 (de)
DK (1)	DK1098871T3 (de)
ES (1)	ES2203163T3 (de)
HU (1)	HUP0102705A3 (de)
ID (1)	ID27261A (de)
IL (1)	IL140586A (de)
NO (1)	NO20010280L (de)
NZ (1)	NZ509327A (de)
PE (1)	PE20000880A1 (de)
PL (1)	PL345621A1 (de)
PT (1)	PT1098871E (de)
RU (1)	RU2223947C2 (de)
SK (1)	SK1032001A3 (de)
TR (1)	TR200100166T2 (de)
TW (1)	TW565546B (de)
WO (1)	WO2000005196A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR031473A1 (es) *	2000-11-20	2003-09-24	Lundbeck & Co As H	Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
DE60212101T2 (de)	2001-01-19	2006-11-23	Akzo Nobel N.V.	Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
CN120965524B (zh) *	2025-10-21	2026-01-09	四川大学	一种(n,n-二甲基氨基)甲酸-4,5-二甲氧基-2-[(1e)-3-甲氧基-丙烯基]苯基酯化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1102011A (en) *	1964-05-21	1968-02-07	Richardson Merrell Spa	Phenol esters of amino acids
GB1160468A (en)	1967-05-08	1969-08-06	May & Baker Ltd	Morpholine Derivative
SU495828A3 (ru) *	1972-10-12	1975-12-15	Ф.Гоффманн-Ля Рош И Ко Аг. (Фирма)	Способ получени мета-производных бензойной кислоты

1999
- 1999-07-16 ID IDW20010160A patent/ID27261A/id unknown
- 1999-07-16 CN CNB998091308A patent/CN1183101C/zh not_active Expired - Fee Related
- 1999-07-16 HU HU0102705A patent/HUP0102705A3/hu unknown
- 1999-07-16 KR KR1020017000592A patent/KR100599142B1/ko not_active Expired - Fee Related
- 1999-07-16 IL IL14058699A patent/IL140586A/en not_active IP Right Cessation
- 1999-07-16 ES ES99936544T patent/ES2203163T3/es not_active Expired - Lifetime
- 1999-07-16 TR TR2001/00166T patent/TR200100166T2/xx unknown
- 1999-07-16 WO PCT/EP1999/005051 patent/WO2000005196A1/en not_active Ceased
- 1999-07-16 AU AU51602/99A patent/AU758808B2/en not_active Ceased
- 1999-07-16 EP EP99936544A patent/EP1098871B1/de not_active Expired - Lifetime
- 1999-07-16 US US09/744,004 patent/US6451854B1/en not_active Expired - Fee Related
- 1999-07-16 AT AT99936544T patent/ATE244697T1/de not_active IP Right Cessation
- 1999-07-16 CA CA002337945A patent/CA2337945A1/en not_active Abandoned
- 1999-07-16 PL PL99345621A patent/PL345621A1/xx not_active IP Right Cessation
- 1999-07-16 DE DE69909486T patent/DE69909486T2/de not_active Expired - Fee Related
- 1999-07-16 JP JP2000561153A patent/JP2002521358A/ja active Pending
- 1999-07-16 RU RU2001104896/04A patent/RU2223947C2/ru not_active IP Right Cessation
- 1999-07-16 PT PT99936544T patent/PT1098871E/pt unknown
- 1999-07-16 BR BR9912291-0A patent/BR9912291A/pt not_active Application Discontinuation
- 1999-07-16 SK SK103-2001A patent/SK1032001A3/sk unknown
- 1999-07-16 NZ NZ509327A patent/NZ509327A/xx unknown
- 1999-07-16 DK DK99936544T patent/DK1098871T3/da active
- 1999-07-21 PE PE1999000731A patent/PE20000880A1/es not_active Application Discontinuation
- 1999-07-21 AR ARP990103567A patent/AR021165A1/es active IP Right Grant
- 1999-07-21 CO CO99045953A patent/CO5080742A1/es unknown
- 1999-07-23 TW TW088112565A patent/TW565546B/zh not_active IP Right Cessation
2001
- 2001-01-17 NO NO20010280A patent/NO20010280L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CO5080742A1 (es)	2001-09-25
PL345621A1 (en)	2002-01-02
IL140586A (en)	2004-06-01
EP1098871A1 (de)	2001-05-16
TR200100166T2 (tr)	2001-05-21
HUP0102705A2 (hu)	2001-12-28
ATE244697T1 (de)	2003-07-15
EP1098871B1 (de)	2003-07-09
ID27261A (id)	2001-03-22
ES2203163T3 (es)	2004-04-01
CA2337945A1 (en)	2000-02-03
DE69909486T2 (de)	2004-05-27
NZ509327A (en)	2003-04-29
AU5160299A (en)	2000-02-14
NO20010280D0 (no)	2001-01-17
AR021165A1 (es)	2002-07-03
AU758808B2 (en)	2003-03-27
TW565546B (en)	2003-12-11
BR9912291A (pt)	2001-04-17
CN1311770A (zh)	2001-09-05
US6451854B1 (en)	2002-09-17
KR20010071905A (ko)	2001-07-31
PT1098871E (pt)	2003-11-28
DE69909486D1 (de)	2003-08-14
DK1098871T3 (da)	2003-10-27
PE20000880A1 (es)	2000-09-12
NO20010280L (no)	2001-03-08
RU2223947C2 (ru)	2004-02-20
JP2002521358A (ja)	2002-07-16
HUP0102705A3 (en)	2002-11-28
IL140586A0 (en)	2002-02-10
WO2000005196A1 (en)	2000-02-03
KR100599142B1 (ko)	2006-07-12
CN1183101C (zh)	2005-01-05

Publication	Publication Date	Title
WO1998029409A1 (en)	1998-07-09	Acid-addition salts of optically active piperidine compound and process for producing the same
SK1032001A3 (en)	2001-08-06	Alpha-amino acid phenyl ester derivatives
CA3249691A1 (en)	2023-10-26	GAMMA-HYDROXYBUTYRATE ADMINISTRATION COMPOUNDS AND THEIR METHODS OF PRODUCTION AND USE
DE69923838D1 (de)	2005-03-31	Stereoisomere von propyl-isopropylacetamid, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zubereitungen
WO2009100095A1 (en)	2009-08-13	3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
CZ2001269A3 (cs)	2001-06-13	Fenylesterové deriváty alfa-aminokyselin
AU2006220097B2 (en)	2011-07-07	Derivatives of aminobutanoic acid inhibiting CPT
FR2610323A1 (fr)	1988-08-05	Enantiomeres de configuration absolue s de derives amide de l'amino-3 quinuclidine, leur procede de preparation et leur application en therapeutique
JP4043363B2 (ja)	2008-02-06	催眠薬としてのアラニン２，６−ジアルコキシフェニルエステル誘導体
MXPA01000721A (en)	2001-12-04	&agr;-AMINO ACID PHENYL ESTER DERIVATIVES
WO2012164055A2 (en)	2012-12-06	New compounds, synthesis and use thereof in the treatment of pain
JP7549439B2 (ja)	2024-09-11	フェニルプロピオンアミド系化合物及びその使用
US20220289668A1 (en)	2022-09-15	N-formylhydroxylamines as neprilysin (nep) inhibitors, in particular as mixed aminopeptidase n (apn) and neprilysin (nep) inhibitors
HK40072833A (en)	2022-12-02	N-formylhydroxylamines as neprilysin (nep) inhibitors, in particular as mixed inhibitors of aminopeptidase n (apn) and neprilysin (nep)
JP2002507591A (ja)	2002-03-12	細胞救済剤としての脂肪族アミノカルボン酸及びアミノホスホン酸、アミノニトリル並びにアミノテトラゾール
HK1253002A1 (zh)	2019-06-06	作为用於治疗癫痫、成瘾和肝细胞癌的gaba氨基转移酶灭活剂的化合物
MC2080A1 (fr)	1991-01-07	Nouveaux sels de phenylpiperazines